AAAAAA

   
Results: 1-9 |
Results: 9
New protease inhibitors prevent gamma-secretase-mediated production of A beta 40/42 without affecting Notch cleavage
Authors: Petit, A Bihel, F da Costa, CA Pourquie, O Checler, F Kraus, JL
Citation: A. Petit et al., New protease inhibitors prevent gamma-secretase-mediated production of A beta 40/42 without affecting Notch cleavage, NAT CELL BI, 3(5), 2001, pp. 507-511
Endogenous beta-amyloid production in presenilin-deficient embryonic mousefibroblasts
Authors: Armogida, M Petit, A Vincent, B Scarzello, S da Costa, CA Checler, F
Citation: M. Armogida et al., Endogenous beta-amyloid production in presenilin-deficient embryonic mousefibroblasts, NAT CELL BI, 3(11), 2001, pp. 1030-1033
Immunochemotherapy in American cutaneous leishmaniasis: Immunological aspects before and after treatment
Authors: Toledo, VPCP Mayrink, W Gollob, KJ Oliveira, MAP da Costa, CA Genaro, O Pinto, JA Afonso, LCC
Citation: Vpcp. Toledo et al., Immunochemotherapy in American cutaneous leishmaniasis: Immunological aspects before and after treatment, MEM I OSW C, 96(1), 2001, pp. 89-98
The caspase-derived C-terminal fragment of beta APP induces caspase-independent toxicity and triggers selective increase of A beta 42 in mammalian cells
Authors: Dumanchin-Njock, C da Costa, CA Mercken, L Pradier, L Checler, F
Citation: C. Dumanchin-njock et al., The caspase-derived C-terminal fragment of beta APP induces caspase-independent toxicity and triggers selective increase of A beta 42 in mammalian cells, J NEUROCHEM, 78(5), 2001, pp. 1153-1161
Role of the proteasome in Alzheimer's disease
Authors: Checler, F da Costa, CA Ancolio, K Chevallier, N Lopez-Perez, E Marambaud, P
Citation: F. Checler et al., Role of the proteasome in Alzheimer's disease, BBA-MOL BAS, 1502(1), 2000, pp. 133-138
alpha-Synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
Authors: Ancolio, K da Costa, CA Ueda, K Checler, F
Citation: K. Ancolio et al., alpha-Synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells, NEUROSCI L, 285(2), 2000, pp. 79-82
Wild-type but not Parkinson's disease-related Ala-53 -> Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli
Authors: da Costa, CA Ancolio, K Checler, F
Citation: Ca. Da Costa et al., Wild-type but not Parkinson's disease-related Ala-53 -> Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli, J BIOL CHEM, 275(31), 2000, pp. 24065-24069
C-terminal maturation fragments of presenilin 1 and 2 control secretion ofAPP alpha and A beta by human cells and are degraded by proteasome
Authors: da Costa, CA Ancolio, K Checler, F
Citation: Ca. Da Costa et al., C-terminal maturation fragments of presenilin 1 and 2 control secretion ofAPP alpha and A beta by human cells and are degraded by proteasome, MOL MED, 5(3), 1999, pp. 160-168
Effect of protein kinase A inhibitors on the production of A beta 40 and Abeta 42 by human cells expressing normal and Alzheimer's disease-linked mutated beta APP and presenilin 1
Authors: Marambaud, P Ancolio, K da Costa, CA Checler, F
Citation: P. Marambaud et al., Effect of protein kinase A inhibitors on the production of A beta 40 and Abeta 42 by human cells expressing normal and Alzheimer's disease-linked mutated beta APP and presenilin 1, BR J PHARM, 126(5), 1999, pp. 1186-1190
Risultati: 1-9 |